The nurse is conducting a comprehensive assessment of a 70-year-old patient with AML who has a white blood cell count of 150,000/μL. Which assessment finding would be most indicative of leukostasis, a life-threatening complication requiring immediate intervention?

Altered mental status with visual disturbances and dyspnea indicates leukostasis affecting CNS and lungs, a life-threatening emergency. Other options represent common AML complications (bleeding, infection, anemia) but are less immediately critical.

Understanding the Clinical Scenario

The patient presents with acute myeloid leukemia (AML) and a white blood cell (WBC) count of 150,000/μL. This extreme elevation defines hyperleukocytosis, a hematologic emergency most often defined as a WBC count greater than 100,000/μL in AML ^[3]. The primary life-threatening complication of hyperleukocytosis is leukostasis, a clinical syndrome caused by the accumulation of leukemic blast cells in the microvasculature, leading to impaired tissue perfusion due to hyperviscosity [1,2]. Recognizing the signs and symptoms of leukostasis is critical because it is associated with severe complications, high early mortality, and requires immediate intervention [2,3].

Analysis of Answer Choices

1. Petechiae and ecchymoses on the lower extremities
While these findings are common in AML due to thrombocytopenia, they are indicative of bleeding risk and impaired hemostasis, not specifically the microvascular occlusion seen in leukostasis. This is a general complication of marrow failure, not the direct result of hyperviscosity from blast cell aggregation.

2. Oral temperature of 101.8°F (38.8°C) with chills
Fever and chills in a patient with AML and a high WBC count are concerning for infection, which is another major risk due to neutropenia despite the high total WBC count (as the cells are non-functional blasts). While a medical emergency, this presentation points toward sepsis or infection, not the direct vascular obstructive pathophysiology of leukostasis.

3. Altered mental status with visual disturbances and dyspnea
This is the correct answer. Leukostasis leads to the occlusion of small blood vessels by leukemic blasts. The clinical manifestations depend on the organ systems involved. Central nervous system (CNS) involvement results in altered mental status and visual disturbances. Pulmonary vascular involvement leads to dyspnea and respiratory distress. The underlying mechanism is vascular engorgement and hyperviscosity, which directly impairs blood flow and oxygen delivery ^[1]. Pulmonary function tests in such patients have demonstrated supranormal diffusing capacity for carbon monoxide (D_LCO), a finding attributed to increased pulmonary capillary blood volume from vascular engorgement, which normalizes with cytoreduction ^[1]. The triad of CNS changes, visual symptoms, and respiratory distress is a classic and ominous presentation of symptomatic leukostasis requiring immediate intervention, such as leukapheresis or prompt initiation of chemotherapy [3,4].

4. Fatigue and weakness with pale mucous membranes
These findings are classic for anemia, another common consequence of bone marrow failure in AML. Like thrombocytopenia, anemia is a general complication of the disease and its treatment, but it does not represent the acute, life-threatening microvascular crisis of leukostasis.

Deep Dive into Leukostasis Pathophysiology and Intervention

The high mortality associated with hyperleukocytosis is mainly secondary to the effects of leukostasis ^[4]. The leukemic blasts in AML are larger and less deformable than mature leukocytes, contributing directly to increased blood viscosity. When they aggregate in the microcirculation of the brain and lungs, they cause endothelial damage, local hypoxia, and hemorrhage. This explains the specific constellation of symptoms in the correct answer. Recognizing this clinical picture is the trigger for emergent management. While definitive therapy is the prompt initiation of chemotherapy ^[4], a procedure called leukapheresis (or therapeutic leukocytapheresis) can be used as an adjunctive strategy to rapidly and safely reduce the WBC count and alleviate symptoms of leukostasis by mechanically removing leukocytes from the peripheral blood [2,4].